FDA approves first new non-opioid pain pill in decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
FDA approves new pain drug Journavx as opioid alternative
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
The Telegraph7 小时
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
“It’s not a slam dunk on effectiveness,” said Michael Schuh of the Mayo Clinic, a pharmacist and pain medicine expert who was not involved in the research. “But it is a slam dunk in that it’s a very ...
FDA approves new type of non-opioid pain medication in two decades
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
thecardiologyadvisor.com5 天
Chronic Widespread Pain and Atherosclerosis May Share a Genetic Pathway
A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain. Chronic widespread pain (CWP) and atherosclerotic disease ...
US drug regulator approves first new type of pain pill in more than 20 years
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
来自MSN20 小时
FDA approves new pain pill with potential to curb opioid addiction
The FDA has approved Vertex Pharmaceuticals' Journavx, a new pain medication that doesn't carry the risks of addiction and ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
York News-Times9 小时
FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...